Head-to-head · Cost-Efficiency Index
Näky vs HealthOn
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Näky
Shoppers who want a distinct oral semaglutide drops product and a separate GLP-1 microdose option.
Visit NäkyHealthOn
Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Visit HealthOnThe verdict
Näky takes it, leading the Cost-Efficiency Index 58 to 57. Näky (benaky.com) is a LegitScript-verified compounded GLP-1 telehealth platform whose marketing pages disclose no pricing, but whose public Shopify product feed shows real flat prices: $145 for compounded semaglutide injections. HealthOn still earns a C — Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Näky.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Näky | HealthOn |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 57/100 |
| Semaglutide / mo | $145/mo (compounded) | $189/mo (1.5 mg dose, compounded) |
| Tirzepatide / mo | $265/mo (compounded) | $295/mo (10 mg dose, compounded) |
| Semaglutide / yr (modeled) | $1,740 | $2,268 |
| Tirzepatide / yr (modeled) | $3,180 | $3,540 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #290 | #297 |
Näky
58/100Where the value is
- Distinct oral semaglutide drops product line ($145) as an alternative to injections — uncommon among compounded GLP-1 brands
- Separate GLP-1 microdose program offered ($185) for patients who want a lower-dose protocol
- LegitScript verification is displayed and checkable for the benaky.com domain
The tradeoffs
- No pricing is shown on any customer-facing marketing page — every page checked (homepage, /pricing, /shop, /tirzepatide, /oral-semaglutide, /weight-loss, /pages/faq) either 404'd or omitted dollar figures; prices had to be pulled from a developer-facing JSON feed, not something a typical visitor would find
- A 'Wegovy® Pill' SKU at $149 borrows Novo Nordisk's registered brand name for what does not appear to be an FDA-approved oral Wegovy product — this needs independent verification before being treated as genuine branded access
HealthOn
57/100Where the value is
- Both compounded semaglutide ($189/mo) and tirzepatide ($295/mo) are priced on their own dedicated product pages, not gated behind an intake
- Quarterly and 12-month prepay options are disclosed with real dollar savings ($549/quarter and $837/quarter respectively)
- Independent third-party batch testing for potency, sterility, pH, and endotoxins is disclosed as a stated policy
The tradeoffs
- The site's sitewide 'Starting at $155/mo*' nav banner is not specific to either medication and requires a 12-month prepay commitment to actually reach — a shopper skimming only the banner will underestimate the real starting cost by $34-140/mo
- No named prescriber, medical director, or specific compounding pharmacy anywhere on the pages checked
Regulatory note: the FDA issued a warning letter to Healthon Inc. dba Healthon in September 2025. We still list and link to HealthOn; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.